[1]
“Breakthrough CAR-T Therapy in Refractory B-Cell Lymphoma: MIOT International Chennai, India Case Study”, hncmc, vol. 3, no. 2, pp. 106–115, Jun. 2025, Accessed: Aug. 07, 2026. Available: https://hnchmc.uz/jour/article/view/231